Metraipolis › archive › dc_ccd01339ee5f
From symptom scales to regulatory endpoints: the evolution and clinical impact of patient-reported outcome measures in myeloproliferative neoplasms — Europe PMC PMID:41138008
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41138008
- DOI
- 10.1007/s10238-[numero omesso]-9
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T01:38:17.410Z
- SHA-256 of the archived text
0ceb38bfe75e832dd241eb355ae50d3c54df08af456804338436810169feb639- Stable URL of this page
https://metraipolis.com/documento/dc_ccd01339ee5f
How to cite
From symptom scales to regulatory endpoints: the evolution and clinical impact of patient-reported outcome measures in myeloproliferative neoplasms — Europe PMC PMID:41138008 — Europe PMC (en), https://europepmc.org/article/MED/41138008 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ccd01339ee5f (Metraipolis archive dc_ccd01339ee5f, sha256 0ceb38bfe75e832dd241eb355ae50d3c54df08af456804338436810169feb639)
BibTeX
@misc{dcccd01339ee5f,
title = {From symptom scales to regulatory endpoints: the evolution and clinical impact of patient-reported outcome measures in myeloproliferative neoplasms — Europe PMC PMID:41138008},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41138008},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ccd01339ee5f; sha256 0ceb38bfe75e832dd241eb355ae50d3c54df08af456804338436810169feb639},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41138008. Agents can read the archived copy with the MCP tool read_document.